🔎 Trials Near Me

Gara Jalqabaatti › Melanoma › Texas › Dallas

Qorannoo klinikaalii Melanoma Dallas, TX keessatti

Qorannoo 20 Melanoma f Dallas fi naannoo isaa (kilomeetira 30 keessatti) hirmaatuu jiru. Qorannoo banaa eenyu akka hirmaatu fi akkamitti garee qorannoo akka quunnaman ilaali.

Takkalaa qorannoo (Ingiliffa)

Qorannoo hirmaatuu barbaadduu? Fuula kana jalatti agarsiisi — $99 guyyaa 30f →

A Study With Combinations of Anti-LAG-3 and Anti-PD-1 Antibodies in Adult Participants With Advanced or Metastatic Melanoma (Harmony Head-to-Head)

Namoota walitti qabaa jiraSadarkaa 3
  • Texas Oncology - Medical City, Dallas
  • Texas Oncology, Dallas
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 25-Ful-2026 · NCT06246916

DESTINY-PANTUMOUR04

Namoota walitti qabaa jiraQorannoo ilaalaa
  • Research Site, Dallas
Umuriin 18 hanga 130 · Saalaa hunda · Haaromfame 25-Ful-2026 · NCT07124000

Safety and Efficacy of NEO212 in Patients With Astrocytoma IDH-mutant, Glioblastoma IDH-wildtype or Brain Metastasis

Namoota walitti qabaa jiraSadarkaa 1/2
  • Baylor, Scott and White Research Institute, Dallas
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 24-Ful-2026 · NCT06047379

ORACLE: Observation of ResiduAl Cancer With Liquid Biopsy Evaluation

Namoota walitti qabaa jiraQorannoo ilaalaa
  • UT Southwestern Medical Center, Dallas
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 14-Ful-2026 · NCT05059444

DOC1021 Dendritic Cell Immunotherapy for Refractory Melanoma

Namoota walitti qabaa jiraSadarkaa 1/2
  • UT Southwestern, Dallas
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 09-Ful-2026 · NCT07288112

Study of AMXT 1501 and DFMO in Combination With Standard Therapies in Advanced Solid Tumors

Namoota walitti qabaa jiraSadarkaa 1/2
  • Texas Oncology - Dallas SCRI, Dallas
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 04-Ful-2026 · NCT07287917

Project: Every Child for Younger Patients With Cancer

Namoota walitti qabaa jiraQorannoo ilaalaa
  • Medical City Dallas Hospital, Dallas
  • UT Southwestern/Simmons Cancer Center-Dallas, Dallas
Hanga umuriin 25 · Saalaa hunda · Haaromfame 25-Hag-2026 · NCT02402244

A Study to Evaluate the Efficacy and Safety of Ifinatamab Deruxtecan (I-DXd) in Subjects With Recurrent or Metastatic Solid Tumors (IDeate-PanTumor02)

Namoota walitti qabaa jiraSadarkaa 1/2
  • Texas Oncology, P.A., Dallas
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 05-Hag-2026 · NCT06330064

A Study of Pembrolizumab (MK-3475) in Pediatric Participants With an Advanced Solid Tumor or Lymphoma (MK-3475-051/KEYNOTE-051)

Namoota walitti qabaa jiraSadarkaa 1/2
  • Call for Information (Investigational Site 0054), Dallas
6 Months – 17 Years · Saalaa hunda · Haaromfame 06-Ado-2026 · NCT02332668

Identification of Metabolic Phenotypes Associated With Melanoma Metastasis

Namoota walitti qabaa jiraQorannoo ilaalaa
  • University of Texas Southwestern Medical Center, Dallas
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 02-Wax-2026 · NCT06400550

Study of RMC-6236 in Patients With Advanced Solid Tumors Harboring Specific Mutations in RAS

Namoota walitti qabaa jiraSadarkaa 1/2
  • Mary Crowley Cancer Research, Dallas
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 15-Cam-2026 · NCT05379985

Neoadjuvant Darovasertib in Primary Uveal Melanoma

Namoota walitti qabaa jiraSadarkaa 3
  • Texas Retina Associates - Dallas, Dallas
  • University of Texas Southwestern Medical Center-5323 Harry Hines Blvd, Dallas
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 06-Cam-2026 · NCT07015190

A Study of VET3-TGI in Patients With Solid Tumors

Namoota walitti qabaa jiraSadarkaa 1
  • Mary Crowley Cancer Research, Dallas
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 07-Elb-2026 · NCT06444815

A Randomized, Phase 2/3 Study to Investigate the Efficacy and Safety of RP2 in Combination With Nivolumab in Immune Checkpoint Inhibitor-Naïve Adult Patients With Metastatic Uveal Melanoma

Namoota walitti qabaa jiraSadarkaa 2/3
  • UT Southwestern Medical Center, Dallas
Umuriin hundi · Saalaa hunda · Haaromfame 02-Elb-2026 · NCT06581406

A Phase 1/2 Clinical Trial to Assess the Safety, Tolerability, Pharmacokinetics and Preliminary Efficacy of HMBD-501 in Patients With HER3-Expressing Solid Tumors

Namoota walitti qabaa jiraSadarkaa 1/2
  • Research Site, Dallas
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 02-Bit-2026 · NCT06956690

A Phase 1 Study of JMT108 in Participants With Advanced Solid Tumors

Namoota walitti qabaa jiraSadarkaa 1
  • NEXT Dallas, Dallas
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 21-Ama-2026 · NCT07317505

A Phase 1/2a Study of DB-1311/BNT324 in Advanced/Metastatic Solid Tumors

Namoota walitti qabaa jiraSadarkaa 1/2
  • Research Site 120, Dallas
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 21-Sad-2025 · NCT05914116

SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry

Namoota walitti qabaa jiraQorannoo ilaalaa
  • Massive Bio SYNERGY-AI site, Dallas
Umuriin hundi · Saalaa hunda · Haaromfame 28-Onk-2025 · NCT03452774

A Clinical Study of Intratumoral MVR-T3011 (T3011) Given as a Single Agent and in Combination With Intravenous Pembrolizumab in Participants With Advanced or Metastatic Solid Tumors

Namoota walitti qabaa jiraSadarkaa 1/2
  • Mary Crowley Cancer Research, Dallas
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 08-Onk-2025 · NCT04370587

A First-in-human, Phase I, Open-label, Multicenter Study of NM1F(Anti-PVRIG) in Patients With Advanced Solid Tumors

Namoota walitti qabaa jiraSadarkaa 1
  • NEXT Oncology, Dallas, Dallas
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 26-Ama-2024 · NCT05746897

Qorannoo Melanoma magaalota biroo keessatti

Qorannoo biroo Dallas keessatti

Kanneen ClinicalTrials.gov irraa argaman, daataa 06-Onk-2026 irratti argame. Qorannoon hundi isaa kan ofii qajeelfama qoodfannaa qaba; gareen qorannoo eenyu akka hirmaatu murteessa.